Upon completion of this course, the student will be able to:
Be able to define Pulmonary Edema
List 2 causes of Pulmonary Edema
List 2 early and 2 late signs and symptoms of Pulmonary Edema
Describe 2 nursing interventions for caring for the patient with a Pulmonary Embolism
Identify 2 appropriate nursing diagnosis’ for patient’s with a Pulmonary Embolism
Explain primary and secondary causes of Pulmonary Hypertension
Discuss 2 medical treatment options for Pulmonary Hypertension
State 2 nursing interventions for the care and management of the patient with Pulmonary Hypertension
Definition
Pulmonary edema refers to extravasation of fluid from the pulmonary vasculature into the interstitium and alveoli of the lung.
Causes
Increased capillary hydrostatic pressure
Increased capillary permeability
Decreased plasma oncotic pressure
Lymphatic obstruction
Pathophysiology
The process of excess fluid accumulation in the lungs (Pulmonary Edema) can be divided into three phases and occurs as follows:
Stage 1 – Fluid transfer is increased into the lung interstitium because lymphatic flow increases.
Stage 2 – The capacity of the lymphatics to drain excess fluid is overwhelmed and fluid begins to accumulate in the interstitial space that surrounds the bronchioles and lung vasculature.
Stage 3 – As fluid continues to build up, increased pressure causes it to track into the interstitial space around the alveoli and disruption to the alveolar membrane occurs. Once this occurs, gas exchange becomes impaired
Contributing Factors
Infectious pulmonary edema (viral or bacterial)
Inhaled toxins
Circulating toxins
Vasoactive substances (histamine, kinins)
Disseminated intravascular coagulation
Immunologic reactions
Radiation pneumonia
Uremia
Near-drowning
Aspiration pneumonia
Smoke inhalation
Adult respiratory distress syndrome
Diagnosis
Clinical findings on assessment
ABG (PO2 low)
Chest X-ray (may reveal fluid in/around lung space or enlarged heart)
Ultrasound (may reveal weak heart muscle or leaking/narrow heart valves)
Symptoms (may develop slowly or acutely)
Early signs:
Shortness of breath on exertion
Sudden respiratory distress after sleep
Difficulty breathing unless sitting upright
Cough
Late signs:
Labored and rapid breathing (causing respiratory alkalosis)
Frothy or bloody sputum
Tachycardia
Cardiac Arrhythmias
Cold, clammy, sweaty, bluish skin
Decreased blood pressure
Thready pulse
Anxiety
Pulse oximetry is commonly less than 85% and arterial Po2 of 30 to 50 mm Hg
Note: Non-specific symptoms may include weakness, light-headedness, abdominal pain, malaise, wheezing and nausea.
Medical Treatment
Medical treatment for Pulmonary Edema is considered an emergency
If possible, find and treat the underlying cause of Pulmonary Edema
O2 via nasal cannula or mask
Intubation and mechanical ventilation may be necessary
If intubated, pulmonary toilet, respiratory medication treatments
Furosemide (Lasix) – increases urine output and works quickly to remove excess fluid from the body
Morphine Sulfate – decreases anxiety and work load of breathing.
Dobutamine – dilates the peripheral vessels to decrease work load of left ventricle
Aspirin – helps decrease blood viscosity for easy oxygen delivery.
If required, titrate inotropic and Vasoactive medications to maintain contractility, preload and afterload parameters
Nursing Care and Management
Assessment:
Identify type of artificial airway or supplemental oxygen
If intubated, assess and document ET Tube size, position and stability
Check respirations for:
Rate
Depth
Rhythm
Symmetry
Accessory muscle use
If present note color, consistency and odor of sputum (pink frothy is usually noted in Pulmonary Edema)
Auscultate lungs for equality and/or adventitious breath sounds
Rales – also known as crackles are heard when fluid or exudates is present in the terminal bronchioles. Most notable on inspiration and are described as fine or coarse
Rhonchi – is produced by passage of air through fluid filled narrow air passages. Heard on both inspiration and expiration and are described as musical, squeaky, rattling, high pitched or low pitched
Pleural Friction Rub – is produced by pleural inflammation and is heard on both inspiration and expiration. Described as rough or grating sound that varies depending on patient position
Interventions:
Monitor for symptoms of heart failure/decreased cardiac output
Monitor vital signs
Observe for confusion, restlessness, agitation (may be sign of decrease cardiac output)
Monitor for chest pain, discomfort (note severity, radiation and duration)
If chest pain present (have patient lie down, give O2, medicate for pain and notify physician)
Cardiac monitor for dysrhythmias
If patient has a Pulmonary Artery Catheter, monitor for increased PAWP, SVR and a decreased cardiac output
O2 per physicians order
If patient intubated, pulmonary toilet, suction, med-neb treatments
Monitor intake and output (kidney perfusion may be compromised if cardiac output low)
Note results of EKG, chest X-ray and other diagnostic tests
Monitor labs work such as ABG, CBC, electrolytes (blood work should be routine)
Assist patient to understand need for lifestyle changes
Side effects of medications
Early reporting of SOB or other respiratory difficulty
Provide specific self-care and disease process information to patient prior to discharge
Possible Nursing Diagnosis (NANDA)
Alteration in Comfort: Pain
Altered Breathing Pattern
Ineffective Airway
Impaired Gas Exchange
Altered Tissue Perfusion: (peripheral, cardiac)
Anxiety
Ineffective Coping
Knowledge Deficit
Impaired Nutrition
Potential for Skin Breakdown
PULMONARY EMBOLISM
Definition
A Pulmonary Embolism is a sudden lodgment of a blood clot in apulmonary artery that causes an obstruction of blood supply to lung tissue.
Causes
A pulmonary embolism is most often caused by blood clots from veins in the legs (Deep Vein Thrombosis DVT) or in the pelvis or hip area. They can also be caused by air bubbles, fat droplets, amniotic fluid or tumor cells that clump and obstruct pulmonary vessels.
Pathophysiology
Once a thrombus separates from its site of origin, it travels through the circulation to the inferior vena cava. From the inferior vena cave, it then passes through the right ventricle which pumps the thrombus into the pulmonary arteries where it finally lodges. Once a Pulmonary embolism has lodged in an artery, a disruption of both pulmonary hemodynamics and gas exchange occurs.
Diagnosis
Physical Exam (Pulmonary Hemodynamics if Pulmonary Artery Catheter in place)
Chest X-ray
Pulmonary ventilation/perfusion scan
Pulmonary Angiogram
Doppler Ultrasound (to rule out DVT)
Venogram (to rule out DVT)
Elevated Troponin Level (which indicates right ventricular micro-infarction)
Elevated pro-B-type peptide Level (which indicates right ventricular overload)
Symptoms (may be vague or resemble other disease processes)
Cough (sudden onset)
Bloody sputum
Shortness of breath (sudden onset)
Splinting of ribs with breathing
Chest pain (under the breast bone described as sharp, stabbing, burning)
Tachycardia
Tachyapnea
Wheezing
Cool clammy skin (may be sweaty)
Bluish skin discoloration
Nasal flaring
Pelvis/Leg pain (DVT)
Swelling of leg (DVT)
Hypotension
Weak pulse
Anxiety/Nervousness
Lightheadedness/Dizziness
Medical Treatment
Anticoagulation - When acute Pulmonary Embolism is suspected, anticoagulation should be started immediately (Heparin 80 unit/kg bolus followed by 18 units/kg/hr). Target of activated partial thromboplastin should be between 60-8- seconds (Patient should eventually be weaned of IV Heparin and oral Warfarin (Coumadin) should be started).
Inferior Vena Caval Filters – Filters can be inserted percutaneously to prevent further Pulmonary Embolism, but they do not stop an already activated thrombolic process. They are indicated for recurrent Pulmonary Embolism and for cases when anticoagulation is contraindicated. Because these filters are retrievable, they can be used on a temporary basis.
Thrombolysis – Recombinant Tissue Plasminogen (rt-PA) is a treatment option for lysing Pulmonary Embolism. If ordered it should be given as a 100mg IV infusion over 2 hours. (This treatment is somewhat controversial due to the fact that most patients with Pulmonary Embolism also have increased systemic arterial pressure and/or moderate to severe right ventricular dysfunction). Other medications include Streptokinase and Urokinase.
Embolectomy – When thrombolysis is contraindicated, a catheter (angio procedure that delivers high velocity jet saline that blasts the clot) can be attempted or surgical embolectomy can be considered
Note: More than 600,000 people in the United States have a pulmonary embolism each year, and more than 60,000 die
Nursing Care and Management
Assessment:
Identify patients at risk for the development of Pulmonary Emboli and put preventative measures in place (ambulation, range of motion, sequential/ted hose).
Assess for Homan’s sign (may indicate impending thrombosis of leg veins)
Complete respiratory assessment to include complaints of pleural pain, pain on inspiration, presence of crackles
Assess for hemoptysis
Interventions:
Avoid leaving IV catheters in place for long periods of time
If SOB, HOB should be in semi-fowler’s position to assist with air distribution
O2 as prescribed (monitor for signs of hypoxia)
Pulse Oximetry
Administer Opioids for sever pain
Administer anticoagulation as prescribed and monitor for untoward bleeding (gums, bruising)
Encourage verbalization of fear and anxiety
Respiratory toilet to include:
Nebulizer treatments
Incentive spirometry
Postural drainage (vibration and percussion)
Possible Nursing Diagnosis (NANDA)
Alteration in Comfort: Pain
Altered Breathing Pattern
Ineffective Airway
Impaired Gas Exchange
Altered Tissue Perfusion: (peripheral, cardiac)
Anxiety
Ineffective Coping
Knowledge Deficit
Impaired Nutrition
Potential for Skin Breakdown
PULMONARY HYPERTENSION
Definition
Pulmonary Hypertension is a continuous high blood pressure in the pulmonary artery caused by increased hydrostatic pressure in the pulmonary system. With Pulmonary Hypertension, pulmonary artery pressures reach mean of 25mmHg or higher (normal mean being 14mmHg).
Causes
The causes of Pulmonary Hypertension are not well known, but primary Pulmonary Hypertension is considered to be an inherited disease process and secondary Pulmonary Hypertension is thought to be caused by an associated disease process such as:
Chronic lung or heart disease
Liver Cirrhosis
Stimulant abuse
HIV infection
Pulmonary Embolism
Connective tissue diseases (Schleroderma, Lupus)
Pathophysiology
Similar to the cause, the pathophysiology of Pulmonary Hypertension is also poorly understood. What is clear is that there is an insult to the endothelium of the lung that results in vascular scaring endothelial dysfunction and smooth muscle proliferation. There are three predominant mechanisms that occur with Pulmonary Hypertension and they are:
Hypoxic vasoconstriction
A decreased size of the pulmonary vascular bed
Volume or pressure overload
Diagnosis
Invasive:
Hemodynamic right heart catheterization (can determine type and severity of Pulmonary Hypertension)
Pulmonary angiography (gives view of pulmonary blood vessels)
Non-Invasive:
ECG and chest x-ray (shows right ventricular hypertrophy and hypertrophy of the pulmonary artery)
Echocardiogram (views effectiveness of hearts pumping ability)
Pulmonary function test (measures lung capacity)
Perfusion lung scan (measures flow of blood)
CT (measures blood flow and can see blockage)
MRI (views and measures blood flow)
Symptoms
Difficulty breathing and shortness of breath are the hallmark symptoms of Pulmonary Hypertension, but other common symptoms include:
Fatigue
Dizziness
Syncope
Dependant edema
Cyanosis (clubbing of fingers)
Tachycardia
Heart palpitation
Medical Treatment
The primary goals of treatment for Pulmonary Hypertension are to treat the underlying cause, reduce symptoms to improve quality of life, slow the growth of smooth muscle cells and increase oxygen supply.
Oxygen therapy for patients who:
Have PaO2 of less than 55 mm Hg at rest from any cause
Desaturate during exercise
Perform better on oxygen therapy
Medication options include:
Anticoagulation – to reduce blood clot formation
Calcium Channel Blockers – to relax smooth muscle and increase oxygen delivery from the heart
Prostacyclin – also produced in cells of the body, it dilates the blood vessels
Treprostinil – another prostacyclin that also relaxes and dilates blood vessels
Bosentan – a relatively new treatment that widens the lung arteries and reduces blood pressure
Nitric oxide inhalation – causes the pulmonary arteries to widen or open, is also being used by some doctors
Sildenafil (Viagra) – causes the pulmonary arteries to open and is being tested for treatment of Pulmonary Hypertension
Diuretics – thought ease symptoms and improve the heart's performance
Note: Lung Transplant is a consideration for severe Pulmonary Hypertension